Decorative image
  • Personal & TAL Partners

    Adviser PartnersSuperannuation Partners

Media release
Home
/
About Us / Landing page
/
Media release landing page
/
TAL equips advisers to better understand diabetes

TAL equips advisers to better understand diabetes

10 July 2018

TAL, a leading Australian life insurance specialist, has developed an education course enabling financial advisers to get the best outcomes for clients who are at risk of, or faced with, diabetes.

Similar to TAL's cancer education course, the diabetes course is run through TAL's industry-leading Risk Academy and presented by TAL's Chief Medical Officer, Dr Priya Chagan. It focuses on understanding the prevalence, diagnosis and treatment of diabetes as well as the medical terminology relevant to both underwriting and when assessing product definition requirements at claims time.

TAL General Manager for Health Services, Dr. Sally Phillips, said, "Diabetes currently represents one of the most challenging public health problems of the 21st century, with the total cost for Australians with Type 2 diabetes amounting to more than $6 billion per year1.

"This course aims to up-skill advisers on the specifics of the medical condition so they can help their clients choose the right insurance cover for their situation at underwriting time and best support clients if they need to claim.

"During the course we also discuss some of the support mechanisms that TAL provides for clients on claim for diabetes, such as information booklets to help them understand their situation and support their return to health.

"By equipping our adviser partners and their clients with this knowledge, we are empowering our customers to live the best life they can through good health" said Dr. Phillips.

The course may be accessed on-demand through TAL's Risk Academy webinar. The webinar is one hour and carries one CPD point accredited through the Association of Financial Advisers (AFA) and the Financial Planning Association of Australia (FPA).


1Diabetes: the silent pandemic and its impact on Australia (2012); Diabetes Australia.

10 July 2018

Related Media Releases

Decorative image

TAL Products

Any financial product advice is general in nature only and does not take into account any person’s objectives, financial situation or needs. Before acting on it, the appropriateness of the advice for any person should be considered, having regard to those factors. Persons deciding whether to acquire or continue to hold life insurance issued by TAL should consider the relevant Product Disclosure Statement (PDS). The Target Market Determination (TMD) for the product is also available.

TAL acknowledges the Traditional Owners of the lands across Australia as the continuing custodians of Country and Culture. We pay our respect to First Nations peoples and their Elders, past and present. 

© TAL Services Limited a Daiichi Life Group Company. "TAL is Australia's leading life insurer" based on Inforce premiums for risk only life insurance policies, NMG Consulting (2022).

Life insurance issued by TAL Life Limited ABN 70 050 109 450 AFSL 237848.